A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to assess the effect of multiple oral doses of canagliflozin on a single oral dose of warfarin.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
• Treatments: Canagliflozin; Warfarin

Criteria

Inclusion Criteria:

• Healthy volunteers with a body mass index between 18 and 30 kg/m

Exclusion Criteria:

• Any blood coagulation disorder determined to be clinically relevant by the Investigator

• Medications known to affect coagulation taken within 7 to 14 days of study entry